Researchers were excited to find that aspirin was just as effective as a more expensive injectable blood thinner in preventing life-threatening blood clots after surgery. However, the adoption of aspirin by doctors and hospitals has been slow, with many sticking to hospital policies, habits, and preferences instead of following the latest evidence. The study involved over 12,000 people with fractures and showed that aspirin was equally effective in preventing death compared to LMWH. The cost and burden of LMWH, especially for uninsured or underinsured individuals, makes aspirin a more accessible and affordable option, highlighting the importance of health equity in medical decisions.
Source link
When $5 aspirin is as good as a $300 injection
